03 March 2022 | News
BC Platforms to drive precision medicine in Asia Pacific region
image credit- istock
Swiss firm BC Platforms (BCP), has announced expansion of its R&D operations in Singapore, which spearheads precision medicine activities in the Asia Pacific region, including China and Japan.
The company also announced a research partnership with Singapore Health Services (SingHealth), Singapore’s largest public healthcare group. SingHealth has joined BCP’s BCRQUEST global data network, in a research partnership to accelerate the genetic understanding and clinical research of diseases prevalent in Asian cohorts, including cancer and cardiovascular diseases.
Niko Hurskainen, Chief Technology Officer, BCP, who will lead the R&D Center in Singapore, commented, “Asian real-world data is under-represented in global life science research. Through our collaborations in the region with national healthcare systems we will enable researchers to have secure access to good quality, carefully curated, data from Asia, to help build novel medical diagnostics and treatments."
The company’s Singapore R&D Centre will support recent Asia-based collaborations including with Japan’s Mitsubishi Space Software, announced Feb 2022, and Thailand’s Bumrungrad International Hospital (BIH), announced October 2021.